Controlled-release granular compositions containing mesalazine and process for the manufacture thereof
作者： Carla Labruzzo , Antonio Mannello
DOI:
关键词:
摘要: The present invention refers to controlled release granular compositions of mesalazine and their use in the treatment inflammatory pathologies intestinal tract. aforesaid comprise: a) a central core comprising an inert substrate; b) intermediate layer one or more physiologically acceptable excipients; c) gastro-resistant coating. then process for obtaining compositions.
lens.org 参考文章(11)
Yoshiyuki Hirakawa, Hiroyuki Yoshino, Minako Kubo Nee Nagata, Kazuo Noda, Pharmaceutical preparation for controlled release of a medicinal compound at a targeted site in the intestinal tract ,(1994)
Junichi Kikuta, Tetsuro Tabata, Toshihiro Shimizu, Effervescent composition and its production ,(1996)
Venkat N. Ravella, Subraman Rao Cherukuri, Revantha Babu Mutyala, Modified release formulations of anti-irritability drugs ,(2006)
Gary Robert Kelm, Koji Kondo, Akio Nakajima, Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery ,(1996)
Hans-Ulrich Petereit, Vishal K. Gupta, Thomas Beckert, Multilayer pharmaceutical product for release in the colon ,(2001)
Francesco Montano, Vittorino Ravelli, Romano Rivolta, Controlled release oral solid forms containing mesalazine as active agent ,(2001)
Curtis Wright, Benjamin Oshlack, Derek Allan Prater, Once-a-day oxycodone formulations ,(2002)
Feng-Jing Chen, Mahesh V. Patel, Solid carriers for improved delivery of active ingredients in pharmaceutical compositions ,(2000)
Gary Lee Manring, Gary Robert Kelm, Pharmaceutical dosage form for colonic delivery ,(1996)
Tadashi Makino, Shin-Ichiro Hirai, Tetsuro Tabata, Spherical granules having core and their production ,(1988)